Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Change in Cash (2023 - 2026)

Cannabis Bioscience International Holdings' Change in Cash history spans 4 years, with the latest figure at -$42.0 for Q1 2026.

  • On a quarterly basis, Change in Cash rose 90.75% to -$42.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$458.0, a 86.18% decrease, with the full-year FY2025 number at $12197.0, up 249.51% from a year prior.
  • Change in Cash hit -$42.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$91.0 in the prior quarter.
  • Over the last five years, Change in Cash for CBIH hit a ceiling of $12404.0 in Q2 2025 and a floor of -$16742.0 in Q2 2023.
  • Historically, Change in Cash has averaged -$1846.1 across 4 years, with a median of -$42.0 in 2026.
  • The widest YoY moves for Change in Cash: up 31905.13% in 2025, down 6048.13% in 2025.
  • Tracing CBIH's Change in Cash over 4 years: stood at -$4409.0 in 2023, then soared by 100.75% to $33.0 in 2024, then tumbled by 375.76% to -$91.0 in 2025, then surged by 53.85% to -$42.0 in 2026.
  • Business Quant data shows Change in Cash for CBIH at -$42.0 in Q1 2026, -$91.0 in Q4 2025, and -$12729.0 in Q3 2025.